These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16832154)

  • 21. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
    Seino H; Miyaguchi S; Yamazaki T; Ota S; Yabe R; Suzuki S
    Arzneimittelforschung; 2007; 57(8):526-31. PubMed ID: 17915639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the L/N-type calcium channel antagonist cilnidipine on morning blood pressure control and peripheral edema formation.
    Narita S; Yoshioka Y; Ide A; Kadokami T; Momii H; Yoshida M; Ando S
    J Am Soc Hypertens; 2011; 5(5):410-6. PubMed ID: 21640687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients.
    Kitahara Y; Saito F; Akao M; Fujita H; Takahashi A; Taguchi H; Hino T; Otsuka Y; Kushiro T; Kanmatsuse K
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):68-73. PubMed ID: 14668570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
    Mancia G; Facchetti R; Parati G; Zanchetti A
    Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
    Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
    Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE).
    Saito I; Suzuki H; Kageyama S; Saruta T
    Clin Exp Hypertens; 2011; 33(2):133-40. PubMed ID: 21269056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population.
    Kawabe H; Saito I; Saruta T
    Hypertens Res; 2005 Jun; 28(6):491-8. PubMed ID: 16231754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Task Force II: blood pressure measurement and cardiovascular outcome.
    Staessen JA; Asmar R; De Buyzere M; Imai Y; Parati G; Shimada K; Stergiou G; Redón J; Verdecchia P;
    Blood Press Monit; 2001 Dec; 6(6):355-70. PubMed ID: 12055415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
    Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
    Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a dual L/N-type calcium channel blocker cilnidipine on blood pressure, pulse rate, and autonomic functions in patients with mild to moderate hypertension.
    Kai T; Kuzumoto Y
    Clin Exp Hypertens; 2009 Oct; 31(7):595-604. PubMed ID: 19886857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
    Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA;
    Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.
    Ishikawa J; Kario K; Eguchi K; Morinari M; Hoshide S; Ishikawa S; Shimada K;
    Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study.
    Kario K; Saito I; Kushiro T; Teramukai S; Ishikawa Y; Mori Y; Kobayashi F; Shimada K
    Hypertension; 2014 Nov; 64(5):989-96. PubMed ID: 25156169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.
    Kushiro T; Kario K; Saito I; Teramukai S; Mori Y; Okuda Y; Shimada K
    Hypertens Res; 2015 Mar; 38(3):178-85. PubMed ID: 25354777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients.
    Minami J; Ishimitsu T; Higashi T; Numabe A; Matsuoka H
    Hypertens Res; 1998 Sep; 21(3):215-9. PubMed ID: 9786607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.